The Heart of Cell Therapy Innovation
Access industry-defining insights across two dedicated content tracks. Explore the shift from ex vivo to in vivo cell therapies, strategies for overcoming the tumour microenvironment, optimising in vivo delivery, advancing point-of-care manufacturing, navigating international clinical trial regulations and building economically sustainable manufacturing models, all to position your programmes for long-term success.
Reuniting the community for its 10th anniversary, reconnect with peers from across the cell therapy ecosystem and gain a unique blend of scientific, commercial and competitive insights to inform sharper strategic decision-making.
What’s New for the 10th Anniversary
Dedicated Investor Session
With the cell therapy funding landscape becoming increasingly competitive, connect directly with VC leaders to understand their position on the European landscape, uncover the qualities that distinguish investment-ready assets and strengthen your position ahead of your next financing milestone.
With insights from:
Global Perspectives
Gain a truly global strategic view of the regulatory frameworks, manufacturing strategies and collaboration opportunities across the EMEA, US, and APAC regions to drive faster, smarter, and more cost-effective development.
With:
8 New Data Presentations
Uncover new data across emerging cell types, modalities and indications including solid tumours, autoimmunity and CNS malignancies, giving you an early view of the innovations shaping the future of the field.
With:
Companies Attending Include